Kymera Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
KYMR
CUSIP
501575104
Type
Equity
Class
COM
Num filers
165
Total reported value, excl. options
$2.70B
Manager Report Date Value ($000) Shares Option Type